Increased spontaneous osteoclastogenesis from peripheral blood mononuclear cells in phenylketonuria

[1]  P. Howe.  Nutrition and Bone Growth , 2009 .

[2]  L. Bonello,et al.  Spontaneous osteoclastogenesis is a predictive factor for bone metastases from non-small cell lung cancer. , 2008, Lung cancer.

[3]  A. Mussa,et al.  Phalangeal quantitative ultrasound in children with phenylketonuria: a pilot study. , 2008, Ultrasound in medicine & biology.

[4]  M. Huemer,et al.  Growth and body composition in children with classical phenylketonuria: Results in 34 patients and review of the literature , 2007, Journal of Inherited Metabolic Disease.

[5]  A. Prentice,et al.  Symposium on ‘Nutrition and health in children and adolescents’ Session 1: Nutrition in growth and development Nutrition and bone growth and development , 2006, Proceedings of the Nutrition Society.

[6]  A. Prentice,et al.  Nutrition and bone growth and development. , 2006, The Proceedings of the Nutrition Society.

[7]  E. Spada,et al.  Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr) , 2006, Journal of endocrinological investigation.

[8]  R. Artuch,et al.  Is deoxypyridinoline a good resorption marker to detect osteopenia in phenylketonuria? , 2005, Clinical biochemistry.

[9]  G. Pescarmona,et al.  Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  S. Colucci,et al.  Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  D. Medeiros,et al.  Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice , 2002, Journal of Inherited Metabolic Disease.

[12]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[13]  E. Schwarz,et al.  Systemic tumor necrosis factor α mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor α–transgenic mice , 2004 .

[14]  E. Schwarz,et al.  Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. , 2004, Arthritis and rheumatism.

[15]  N. Barthe,et al.  The impact of the control of serum phenylalanine levels on osteopenia in patients with phenylketonuria , 2002, European Journal of Pediatrics.

[16]  C. Scriver.  The hyperphenylalaninemia : phenylalanine hydroxylase deficiency , 2001 .

[17]  S. Teitelbaum,et al.  Bone resorption by osteoclasts. , 2000, Science.

[18]  A. Flanagan,et al.  Human osteoclasts derive from CD14‐positive monocytes , 1999, British journal of haematology.

[19]  K. Schulpis,et al.  Bone mineral status in children with phenylketonuria under treatment , 1998, Acta paediatrica.

[20]  K. Scheidhauer,et al.  Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography , 1998, Acta paediatrica.

[21]  G. Chan,et al.  Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control. , 1992, The American journal of clinical nutrition.